Elicera Therapeutics AB Working Capital to Net Assets Ratio
Elicera Therapeutics AB working capital to net assets ratio. Elicera Therapeutics AB (ELIC) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of Skr30.33 Million (current assets of Skr37.30 Million minus current liabilities of Skr6.97 Million) is measured against net assets of Skr30.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Elicera Therapeutics AB (ELIC) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Elicera Therapeutics AB (2014–2024)
Working capital to net assets ratio of Elicera Therapeutics AB from 2014 to 2024. This chart shows how Elicera Therapeutics AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of Skr30.33 Million against net assets of Skr30.33 Million SEK. See Elicera Therapeutics AB (ELIC) defensive interval to measure how many days the company can operate on defensive assets alone.
Elicera Therapeutics AB Working Capital to Net Assets Ratio by Year (2014–2024)
Elicera Therapeutics AB working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Elicera Therapeutics AB from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ELIC total asset value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.0% | Skr20.77 Million | Skr20.77 Million | Skr27.56 Million | Skr6.79 Million | ▲ +0.1 pp |
| 2023 | 99.9% | Skr16.39 Million | Skr16.40 Million | Skr30.17 Million | Skr13.78 Million | ▲ +1.5 pp |
| 2022 | 98.5% | Skr32.29 Million | Skr32.80 Million | Skr45.80 Million | Skr13.51 Million | ▼ -0.5 pp |
| 2021 | 99.0% | Skr51.71 Million | Skr52.24 Million | Skr54.21 Million | Skr2.50 Million | ▲ +4.2 pp |
| 2020 | 94.8% | Skr9.71 Million | Skr10.24 Million | Skr12.06 Million | Skr2.35 Million | ▲ +81.6 pp |
| 2019 | 13.2% | Skr80.92K | Skr614.10K | Skr84.92K | Skr4.00K | ▲ +6.3 pp |
| 2018 | 6.9% | Skr55.16K | Skr805.16K | Skr59.16K | Skr4.00K | ▼ -93.1 pp |
| 2017 | 100.0% | Skr808.69K | Skr808.69K | Skr812.69K | Skr4.00K | ▲ +0.0 pp |
| 2016 | 100.0% | Skr813.65K | Skr813.65K | Skr938.25K | Skr124.60K | ▲ +0.0 pp |
| 2015 | 100.0% | Skr818.47K | Skr818.47K | Skr1.19 Million | Skr366.76K | ▲ +0.0 pp |
| 2014 | 100.0% | Skr390.63K | Skr390.63K | Skr987.50K | Skr596.87K | — |